Publication:
Cardiovascular Diabetology Volume 22
Cardiovascular Diabetology Volume 22
| dc.date.accessioned | 2023-11-30T06:15:31Z | |
| dc.date.available | 2023-11-30T06:15:31Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | (Temporal relationship between triglyceride-glucose index and blood pressure and their joint cumulative effect on cardiovascular disease risk: a longitudinal cohort study - https://doi.org/10.1186/s12933-023-02058-1) - (SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1 - https://doi.org/10.1186/s12933-023-02040-x) - (Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial - https://doi.org/10.1186/s12933-023-02027-8) - (Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands - https://doi.org/10.1186/s12933-023-02053-6) - (Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice - https://doi.org/10.1186/s12933-023-02064-3) | |
| dc.identifier.uri | http://repository.vlu.edu.vn:443/handle/123456789/10556 | |
| dc.language.iso | en_US | |
| dc.relation.issn | 14752840 | |
| dc.title | Cardiovascular Diabetology Volume 22 | |
| dc.type | Resource Types::text::journal | |
| dspace.entity.type | Publication | |
| oaire.citation.volume | 22 |
Files
Original bundle
1 - 1 of 1